Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

HMR-3004: a new ketolide from Hoechst Marion Roussel

Oct. 14, 1997

Extensive preclinical and clinical data on moxifloxacin presented at ICAAC

Oct. 14, 1997

New results reported for Glaxo Wellcome's anti-HCMV agent at ICAAC

Oct. 14, 1997

MycoTox awarded four SBIR awards for antifungal drug discovery

Oct. 14, 1997

NIH grant to support development of CytRx's Protox

Oct. 13, 1997

GM-237354: a new antifungal sordarin derivative from Glaxo Wellcome

Oct. 13, 1997

Cubist and Merck expand antibiotic collaboration

Oct. 10, 1997

Mechanism of action of oxazolidinones elucidated

Oct. 9, 1997

CFC-222: a promising therapeutic for bacterial infections

Oct. 9, 1997

Significant research efforts center on new ketolide at Hoechst Marion Roussel

Oct. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...